Healthcare Global Enters Renewable Deal With EVRE Stake

BENGALURU — Healthcare Global Enterprises Limited has announced that its subsidiary, HCG Manavata Oncology LLP, entered into a definitive agreement to acquire a 26 percent equity stake in solar project developer Epic Vighnaharta Renewable Energy Private Limited for ₹38 lakh.

Captive Power Arrangement to Drive Green Energy Adoption

According to regulatory filings submitted to stock exchanges on August 4, 2026, the acquisition involves the subscription of 3,80,000 equity shares of ₹10 each, paid entirely in cash consideration. Following the transaction, the LLP will hold 26 percent of Epic Vighnaharta Renewable Energy Private Limited on a fully diluted basis, giving Healthcare Global Enterprises Limited an indirect stake of up to 26 percent.

Epic Vighnaharta Renewable Energy Private Limited is currently setting up a solar power plant in Mangalwedha, located in the Solapur district of Maharashtra, featuring an initial capacity of 1.3 MWp. The primary objective of the equity acquisition is to qualify the LLP as a designated captive user under Indian power regulations, allowing the renewable energy entity to supply generated electricity directly for internal healthcare operations.

Strategic Background and Timeline

Incorporated on March 22, 2025, and headquartered in Mumbai, Epic Vighnaharta Renewable Energy Private Limited focuses on power generation from clean energy assets. As a development-stage project, the company recorded no operational revenue during FY24, FY25, and FY26.

The transaction requires no special statutory approvals beyond ordinary business licenses and is slated for completion in the second quarter of FY2027, subject to customary closing terms. The deal does not fall under related-party transaction rules.

Official Sources Section

Transaction specifics were disclosed in a formal regulatory filing submitted by Healthcare Global Enterprises Limited to the National Stock Exchange of India Limited and BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Quote Section

According to official regulatory filings, "The LLP would acquire 26% stake in EVRE to qualify as a captive user of the power plant operated by EVRE, so that EVRE can supply the electricity generated by its plant to the LLP for its own use."

Why It Matters

Securing captive solar power status enables Healthcare Global Enterprises Limited to optimize long-term operational costs across regional healthcare facilities while advancing sustainability goals and lowering utility overheads through renewable energy consumption.

Key Facts at a Glance

• Investment Amount: ₹38 lakh cash consideration for a 26 percent equity stake.

• Energy Source: 1.3 MWp solar power plant under construction in Solapur, Maharashtra.

• Regulatory Compliance: Establishes captive power user eligibility for HCG Manavata Oncology LLP.

• Target Timeline: Expected completion within Q2 FY 2027.

FAQ Section

Why is Healthcare Global Enterprises acquiring a stake in a solar company? The acquisition enables its subsidiary to achieve captive power status, permitting direct procurement of solar electricity for operational usage.

What is the financial value of the transaction? The total acquisition cost is ₹38 lakh for 3,80,000 equity shares at ₹10 each.

When is the acquisition expected to close? The transaction is expected to conclude within the second quarter of FY 2027.

Source: Official regulatory announcements submitted to National Stock Exchange of India Limited, BSE Limited, and Healthcare Global Enterprises Limited.